rifaximin (xifaxan) Report issue

Small molecule Orphan Drug FDA Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$6.1758

VA Big4

$14.3870 - $27.4235

VA FSS

$14.3870 - $27.4235

NADAC

$23.0267 - $44.0567

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
rifaximin 200 mg (TABLET) $14.3870 VA Big4
  • XIFAXAN (30)
    		•  Bausch Health US, LLC
    rifaximin 200 mg (TABLET) $14.3870 VA FSS
  • XIFAXAN (30)
    		•  Bausch Health US, LLC
    rifaximin 200 mg (TABLET) $23.0267 NADAC brand
  • XIFAXAN (1)
    		•  Salix Pharmaceuticals, Inc.
    rifaximin 550 mg (TABLET) $6.1758 AUS PBS generic
  • Xifaxan (56)
    		•  Norgine Pty Limited
    rifaximin 550 mg (TABLET) $27.4235 VA Big4
  • XIFAXAN (60)
    		•  Bausch Health US, LLC
  • XIFAXAN (60)
    		•  Bausch Health US, LLC
    rifaximin 550 mg (TABLET) $27.4235 VA FSS
  • XIFAXAN (60)
    		•  Bausch Health US, LLC
  • XIFAXAN (60)
    		•  Bausch Health US, LLC
    rifaximin 550 mg (TABLET) $44.0567 NADAC brand
  • XIFAXAN (1)
    		•  Salix Pharmaceuticals, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue